MENU
+Compare
MEOBF
Stock ticker: OTC
AS OF
Jun 23 closing price
Price
$0.96
Change
-$0.00 (-0.00%)
Capitalization
1.53B

MEOBF Mesoblast Ltd. Forecast, Technical & Fundamental Analysis

Mesoblast Ltd is a biotechnology company... Show more

MEOBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MEOBF with price predictions
Jun 30, 2025

MEOBF in upward trend: price may ascend as a result of having broken its lower Bollinger Band on June 13, 2025

MEOBF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 22 cases where MEOBF's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 42 cases where MEOBF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 30, 2025. You may want to consider a long position or call options on MEOBF as a result. In of 44 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for MEOBF turned negative on June 13, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 34 similar instances when the indicator turned negative. In of the 34 cases the stock turned lower in the days that followed. This puts the odds of success at .

MEOBF moved below its 50-day moving average on June 13, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for MEOBF crossed bearishly below the 50-day moving average on June 13, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MEOBF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.657) is normal, around the industry mean (16.392). P/E Ratio (0.000) is within average values for comparable stocks, (58.219). MEOBF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.307). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (208.333) is also within normal values, averaging (258.362).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MEOBF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
MEOBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MEOBF is expected to report earnings to rise 56.00% to -2 cents per share on May 29

Mesoblast Ltd. MEOBF Stock Earnings Reports
Q1'24
Est.
$-0.02
Q4'24
Est.
$-0.01
Q3'24
Est.
$-0.01
Q4'23
Est.
$-0.02
Q3'23
Est.
$-0.02
The last earnings report on February 26 showed earnings per share of -1 cents, meeting the estimate of -1 cents. With 1.00K shares outstanding, the current market capitalization sits at 1.53B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Level 38, 55 Collins Street
Phone
+61 396396036
Employees
83
Web
https://www.mesoblast.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BBVLX17.810.08
+0.46%
Bridge Builder Large Cap Value
MGWRX60.260.24
+0.40%
MFS Global Growth R2
PASRX20.290.07
+0.35%
Putnam Dynamic Asset Allocation Gr R
BRSTX14.100.01
+0.07%
MFS Blended Research Small Cap Eq R3
SECUX37.43N/A
N/A
NAA Mid Growth A

MEOBF and Stocks

Correlation & Price change

A.I.dvisor tells us that MEOBF and RLYB have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MEOBF and RLYB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEOBF
1D Price
Change %
MEOBF100%
N/A
RLYB - MEOBF
25%
Poorly correlated
+1.62%
ADIL - MEOBF
24%
Poorly correlated
N/A
MMIRF - MEOBF
10%
Poorly correlated
N/A
MLLCF - MEOBF
6%
Poorly correlated
N/A
IPHYF - MEOBF
5%
Poorly correlated
N/A
More